(Q36947423)
English
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcino
scientific article published on 13 July 2012
Statements
1 reference
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcino (English)
1 reference
Jill Gilbert
1 reference
Ju Whei Lee
1 reference
Athanassios Argiris
1 reference
Missak Haigentz
1 reference
Lawrence Eric Feldman
1 reference
Minyoung Jang
1 reference
Pattatheyil Arun
1 reference
Carter Van Waes
1 reference
Arlene A Forastiere
1 reference
13 July 2012
1 reference
1 reference
942-948
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference